A University of Newcastle study has revealed that heart patients with a history of cancer are less likely to receive the heart medications they need.
A research project underway in western Sydney could see marked improvements for patients with atrial fibrillation.
A new heart transplant method means that a donated heart can now be transported and preserved for longer than previously possible.
An Australian-developed anti-clotting drug could treat one of the most devastating, life-threatening complications of COVID-19 — microscopic blood clots.
Tens of thousands of Australians with chronic diseases are putting themselves at risk by missing vital visits to their GP.
Researchers from Monash University are developing a device to safely and effectively treat the most common cardiovascular disease: atherosclerosis, or narrowing of the arteries.
The Heart Foundation is urging those with conditions such as heart failure, and those aged 65 years and over, to be aware of the risks to their health and the need to protect themselves.
Unlike the Ganesan study, published in Internal Medicine Journal, GenesisCare cardiologists have found marked variation in complication rates for cardiac device implantation.
Public and private hospitals have similar safety outcomes for pacemaker and defibrillator implant surgeries, according to a comparative study.
The release of new European guidelines on dyslipidaemias has called Australia’s LDL-C targets into question.
Assessment times for patients presenting with chest pains can be safely reduced, easing pressure on often overcrowded emergency departments.
In the 'Hope 4' trial, care was led by non-physician health workers using a computer tablet to help decision-making, working closely with physicians.
A man's chest caught on fire during emergency heart surgery after a dry surgical pack ignited.
Women who conceive via IVF are five times more likely to experience heart failure than women who conceive naturally, according to a new study.
New research suggesting that joint supplements may reduce the risk of cardiovascular disease events has been met with scepticism by Australian experts.